Not Recommended - Chapter 7 Obstetrics, gynaecology, and urinary-tract disorders
Prostaglandins and oxytocics BNF 7.1.1
(SMC No 309/06 - August 2006)
Carbetocin (Pabal®)t 100 mcg/1ml solution for injection, is not recommended for use within NHSScotland for the prevention of uterine atony and excessive bleeding following delivery of the infant by Caesarean section under epidural or spinal anaesthesia
Drugs for urinary frequency, enuresis, and incontinence BNF section 7.4.2
Flavoxate Hydrochloride is an antimuscarinic drug with less marked side-effects than oxybutynin but it is less effective and is therefore not recommended (See 7.4).
Oxybutinin XL tablets (Lyrinel XL®) for second line use in patients intolerant of immediate release oxybutinin. The side effect incidence and profile in the papers presented did not differ substantially between immediate release and modified release formulations. Not recommended for use in NHS Grampian, cost-effective alternatives available (See 7.4). June 2006
Propiverine tablets (Detrunorm®) for idiopathic and neuropathic bladder overactivity. Propiverine is better tolerated than oxybutynin but has a similar adverse effects profile to the other formulary choice products - tolterodine and trospium . Not recommended for use in NHS Grampian, cost-effective alternatives available (See 7.4). January 2006.